Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-25T17:06:12.709Z Has data issue: false hasContentIssue false
  • English
  • Français

A survey of the prescribing of selective serotonin reuptake inhibitors by psychiatrists

Published online by Cambridge University Press:  02 January 2018

John Lawton  and
Prakash Naik
John Lawton*
Affiliation:
Nottingham Healthcare NHS Trust, The Wells Road Centre, Wells Road, Nottingham NG3 3AA
Prakash Naik
Affiliation:
Lyndon Clinic, Hobs Meadow, Solihull West Midlands B92 8PW
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Questionnaires were sent to 92 doctors asking them about aspects of their antidepressant prescribing; 72 returned them. Sixty had prescribed selective serotonin reuptake inhibitors (SSRIs) in the previous year. The ratio of SSRIs to all antidepressants prescribed in the previous year exceeded 40% in only eight doctors. Inability to tolerate and failure to respond to established antidepressants were the most common indications for prescribing SSRIs. Side effects and cost were the most common reasons deterring doctors from prescribing SSRIs. SSRIs being new products and doubts regarding their efficacy were factors that were significantly more likely to deter ‘doctors of other grades' than consultants from prescribing them. Fluoxetine and paroxetine were the most frequently prescribed SSRIs.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 19 , Issue 12 , December 1995 , pp. 740 - 743
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1995

References

Drug and Therapeutics Bulletin (1993a) Selective Serotonin Reuptake Inhibitors for Depression? Drug and Therapeutics Bulletin, 31, 57–8.Google Scholar
Drug and Therapeutics Bulletin (1993b) Prescribing costs. Drug and Therapeutics Bulletin, 31, 87.CrossRefGoogle Scholar
Eccleston, D. (1993) The economic evaluation of antidepressant drug therapy. British Journal of Psychiatry, 163, 5–6.CrossRefGoogle Scholar
Mackay, A. V. P. (1993) Foreword. In A Review of the Selective Serotonin Reuptake Inhibitors 1993 (eds A. Mackay, P. Pratt & B. Leonard). Clwyd: Unicorn Health Communications Services.Google Scholar
Pratt, P. (1993) Pharmacokinetics and interactions of the SSRIs. In A Review of the Selective Serotonin Reuptake Inhibitors (eds A. Mackay, P. Pratt & B. Leonard). Clwyd: Unicorn Health Communications Services.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.